The Utility of ChatGPT in Diabetic Retinopathy Risk Assessment: A Comparative Study with Clinical Diagnosis

Abstract

Purpose

To evaluate the ability of an artificial intelligence (AI) model, ChatGPT, in predicting the diabetic retinopathy (DR) risk.

Methods

This retrospective observational study utilized an anonymized dataset of 111 patients with diabetes who underwent a comprehensive eye examination along with clinical and biochemical assessments. Clinical and biochemical data along with and without central subfield thickness (CST) values of the macula from OCT were uploaded to ChatGPT-4, and the response from the ChatGPT was compared to the clinical DR diagnosis made by an ophthalmologist.

Results

The study assessed the consistency of responses provided by ChatGPT, yielding an Intraclass Correlation Coefficient (ICC) value of 0.936 (95% CI, 0.913–0.954, p < 0.001) (with CST) and 0.915 (95% CI, 0.706–0.846, p < 0.001) (without CST), both situations indicated excellent reliability. The sensitivity and specificity of ChatGPT in predicting the DR cases were evaluated. The results revealed a sensitivity of 67% with CST and 73% without CST. The specificity was 68% with CST and 54% without CST. However, Cohen’s kappa revealed only a fair agreement between ChatGPT predictions and clinical DR status in both situations, with CST (kappa = 0.263, p = 0.005) and without CST (kappa = 0.351, p < 0.001).

Conclusion

This study suggests that ChatGPT has the potential of a preliminary DR screening tool with further optimization needed for clinical use.

Keywords:

• ChatGPT
• artificial intelligence
• diabetic retinopathy
• diabetes

Disclosure

No conflicting relationship exists for any author.

Additional information

Funding

There is no funding to report.